mail
versión imprimible
 
 

4th Glioblastoma Drug Development Summit

Evvnt Promotion / evvnt
-
14.03.2023 - 16.03.2023  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, Massachusetts, USA
Time: 08:00 - 18:00
 
Temas de la conferencia
Accelerate the Practical Translation and Clinical Development of Meaningful Therapies for the Treatment of Glioblastoma and Other Life Threatening CNS Tumors
Glioblastoma continues to be one of the most devasting diseases, with a severe lack of options available for treatment. Between drug delivery challenges, inefficient preclinical models and post-treatment recurrence, this is one of the most difficult tumors to develop treatments for.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/1427445-2?pid=4832

Speakers: Adilia Hormigo, Professor in the Department of Neurology, Medicine (Division of Hematology- Oncology), Albert Einstein College of Medicine, and more.
 

Información e inscripción:

https://go.evvnt.com/1427445-3?pid=4832
Ms. Aarti Diwan
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 4997.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Charité International AcademyCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioEuropean Public Health Association (EUPHA)Ärztekammer für WienÖsterreichisches Rotes KreuzAMREF - African Medical and Research FoundationÄrzte der WeltSwiss Tropical and Public Health Institute